Cove Street Capital LLC decreased its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 54.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 160,261 shares of the company's stock after selling 188,906 shares during the quarter. Viemed Healthcare makes up about 1.5% of Cove Street Capital LLC's holdings, making the stock its 27th biggest position. Cove Street Capital LLC owned approximately 0.41% of Viemed Healthcare worth $1,285,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the business. National Bank of Canada FI boosted its holdings in Viemed Healthcare by 91.2% in the third quarter. National Bank of Canada FI now owns 3,346 shares of the company's stock worth $25,000 after purchasing an additional 1,596 shares in the last quarter. R Squared Ltd acquired a new position in shares of Viemed Healthcare during the 4th quarter valued at about $41,000. PDT Partners LLC bought a new position in shares of Viemed Healthcare in the 3rd quarter valued at approximately $78,000. Walleye Capital LLC acquired a new stake in Viemed Healthcare in the 3rd quarter worth approximately $87,000. Finally, EntryPoint Capital LLC bought a new stake in Viemed Healthcare during the fourth quarter worth approximately $92,000. Institutional investors own 74.24% of the company's stock.
Viemed Healthcare Stock Performance
VMD stock traded down $0.14 during midday trading on Tuesday, hitting $7.14. 49,468 shares of the company traded hands, compared to its average volume of 135,679. The business has a 50 day simple moving average of $7.80 and a 200-day simple moving average of $8.19. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a twelve month low of $6.21 and a twelve month high of $9.81. The stock has a market capitalization of $282.19 million, a price-to-earnings ratio of 26.44 and a beta of 1.50.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
See Also

Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.